{
  "abstract": "Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Although dysglycaemia is a major risk factor, additional cardiometabolic disturbances contribute to the development of MASLD. This study aimed to identify parameters that distinguish MASLD among dysglycaemic individuals using body composition, anthropometric, biochemical, and imaging-based assessments.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Medical Biochemistry, Gazi University Faculty of Medicine, Ankara, Türkiye",
    "Department of Medical Biochemistry, Institute of Health Sciences, Gazi University, Ankara, Türkiye",
    "Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Türkiye",
    "Department of Radiology, Faculty of Medicine, Gazi University, Ankara, Türkiye"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Ünal Kübranur"
    },
    {
      "affs": [
        0
      ],
      "name": "İbrahimkhanlı Leyla"
    },
    {
      "affs": [
        1
      ],
      "name": "Erol Mehmet Emre"
    },
    {
      "affs": [
        2
      ],
      "name": "Altıntop Sabri Engin"
    },
    {
      "affs": [
        3
      ],
      "name": "İbrahimkhanlı Nemat"
    },
    {
      "affs": [
        3
      ],
      "name": "Şendur Halit Nahit"
    },
    {
      "affs": [
        3
      ],
      "name": "Cerit Mahi Nur"
    },
    {
      "affs": [
        2
      ],
      "name": "Cerit Ethem Turgay"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/a6v4r661gcthp.bib",
  "cited_by": 0,
  "doi": "10.1515/med-2026-1556",
  "fulltext_url": "https://doi.org/10.1515/med-2026-1556",
  "id": "a6v4r661gcthp",
  "issns": [
    "2391-5463"
  ],
  "landing_url": "https://doi.org/10.1515/med-2026-1556",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "R"
    ],
    [
      "openalex",
      "2713|Liver Disease Diagnosis and Treatment"
    ]
  ],
  "openalex": "W7223465878",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-26",
  "publisher": "De Gruyter",
  "ris": "https://research.draconitic.com/paper/a6v4r661gcthp.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T13:47:23Z",
      "native_id": "a5c04c9c087d4968b235f883c33e9b0a",
      "source": "doaj",
      "url": "https://doi.org/10.1515/med-2026-1556"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Liver Disease Diagnosis and Treatment",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia",
  "title_text": "Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T13:47:23Z",
  "url": "https://research.draconitic.com/paper/a6v4r661gcthp",
  "venue": "Open Medicine",
  "versions": []
}